WinstonWınston
Back
Mesa Laboratories logo

Mesa Laboratories

MLAB
53
Medical - Equipment & Services · Healthcare
Price
$124.76
+5.61 (+4.71%)
Market Cap
$698.1M
Exchange
NASDAQ
Winston Score
53
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Exceptional
Stability
Good
Valuation
Good
Dividends
Weak

Share count rising — dilution

+4.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 5.3M (2022) → 5.6M (2026)

Winston Score History

The full picture

Mesa Laboratories makes specialized testing and measurement tools used in healthcare, pharmaceuticals, and food safety. Its core products include biological indicators (used to verify that sterilization equipment is working properly), continuous monitoring systems, and calibration instruments. The company sells mainly to hospitals, drug manufacturers, and food processing companies that need to prove their equipment meets strict safety standards.

Mesa Labs earns revenue by selling both physical instruments and consumable products — like the biological indicators that get used up and must be reordered regularly. It operates primarily in North America and Europe, with annual revenues around $200 million. The recurring consumables business gives it some pricing stability, but the company has grown partly through acquisitions, which has left it carrying meaningful debt and a low return on invested capital. The key challenge going forward is improving profitability and integrating past acquisitions efficiently, rather than relying on further deal-making to drive growth.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+1.0% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-42.5% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$20M/ year

Flat (+4% vs prior year)

8.2% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

12.4%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$31M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Mesa Laboratories is growing revenue at 1% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
64.9%
Premium pricing power — 64.9% gross margin
Profit after running costs
Operating Margin
11.7%
Modest — 11.7% operating margin
Return on the money invested
ROCE
7.8%
Weak — 7.8% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+3.0%
Slow sales growth (+3.0% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
1160%
Turns 1160% of profit into real cash
Spare cash per sale
FCF Margin
20.2%
Converts sales into free cash efficiently (20.2%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.52
Conservative — low debt load (0.52)
Covers its interest
Interest Cover
2.07x
Tight — interest eats into profit (2.1x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
145.1x
Expensive — P/E 145.1

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+136.5
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (145.1 → 8.6)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.63%
Small dividend — 0.63% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial